Samsung Biologics said Wednesday it had entered a strategic partnership with the Coalition for Epidemic Preparedness Innovations to support the manufacturing of vaccines for future pandemics.
The agreement was signed Tuesday at the Conrad Seoul, with Samsung Biologics CEO John Rim and CEPI CEO
Continue Reading on The Korea Herald
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.